James Healy Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
James Healy has an estimated net worth of at least $45.4 million*, as of Dec. 18, 2024. They own 46,004 shares of NTRA stock. They have sold 1.1 million shares of NTRA stock since 2021, for an estimated $37.7 million.
James Healy $NTRA SEC Form 4 Insider Trading
James Healy has filed a total of 3 insider trades in $NTRA since 2021. Their most recent trade was a sale of 644,000 shares, made on Dec 13, 2023. Their largest trade was a sale of 644,000 shares, made on Dec 13, 2023. We estimate that they now own 46,004 shares of $NTRA, worth an estimated $7.7 million.
Insider Trading at $NTRA
There have been a total of 602 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 3.0 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 338 shares reported by Jonathan Sheena (None), made on Dec 18, 2024.
History of Insider Stock Trades by James Healy
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
BIOA | Purchase | 11,113 | Sep 27, 2024 | Sept. 27, 2024, 4:22 p.m. |
BIOA | Purchase | 18,353 | Sep 27, 2024 | Sept. 27, 2024, 4:22 p.m. |
BIOA | Purchase | 21,814 | Sep 27, 2024 | Sept. 27, 2024, 4:22 p.m. |
BIOA | Purchase | 26,497 | Sep 27, 2024 | Sept. 27, 2024, 4:22 p.m. |
BIOA | Purchase | 588,888 | Sep 27, 2024 | Sept. 27, 2024, 4:22 p.m. |
RAPP | Purchase | 2,625 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 4,661 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 3,657 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 3,630 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 2,748 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 4,878 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 3,828 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 3,799 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 2,559 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 4,544 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 3,565 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 3,538 | Jul 01, 2024 | July 3, 2024, 8:04 p.m. |
RAPP | Purchase | 470,589 | Jun 10, 2024 | June 10, 2024, 7:38 p.m. |
RAPP | Purchase | 25,455 | Jun 10, 2024 | June 10, 2024, 7:38 p.m. |
RAPP | Purchase | 26,278 | Jun 10, 2024 | June 10, 2024, 7:38 p.m. |
RAPP | Purchase | 17,861 | Jun 10, 2024 | June 10, 2024, 7:38 p.m. |
RAPP | Purchase | 18,641 | Jun 10, 2024 | June 10, 2024, 7:38 p.m. |
AVBP | Purchase | 444,444 | Jan 30, 2024 | Jan. 31, 2024, 5:10 p.m. |
NTRA | Sale | 644,000 | Dec 13, 2023 | Dec. 22, 2023, 3:21 p.m. |
CINC | Sale | 6,000 | Nov 28, 2022 | Feb. 27, 2023, 10:15 p.m. |
NTRA | Sale | 2,400 | Nov 16, 2022 | Jan. 18, 2023, 12:12 p.m. |
KRTX | Sale | 6,027 | Jan 13, 2023 | Jan. 17, 2023, 9:43 p.m. |
CINC | Purchase | 6,000 | Aug 11, 2022 | Aug. 15, 2022, 3:45 p.m. |
CINC | Purchase | 500,000 | Aug 11, 2022 | Aug. 15, 2022, 3:45 p.m. |
KRTX | Purchase | 9,129 | Jun 29, 2022 | July 1, 2022, 1:23 p.m. |
KRTX | Purchase | 6,832 | Jun 29, 2022 | July 1, 2022, 1:23 p.m. |
KRTX | Purchase | 4,039 | Jun 29, 2022 | July 1, 2022, 1:23 p.m. |
KRTX | Purchase | 27,777 | Jun 29, 2022 | July 1, 2022, 1:23 p.m. |
KRTX | Purchase | 48,062 | Jun 30, 2022 | July 1, 2022, 1:23 p.m. |
KRTX | Purchase | 24,161 | Jun 30, 2022 | July 1, 2022, 1:23 p.m. |
KRTX | Purchase | 47 | Apr 01, 2022 | April 13, 2022, 8 p.m. |
CINC | Purchase | 325,000 | Jan 11, 2022 | Jan. 13, 2022, 5:33 p.m. |
CHRS | Sale | 48,329 | Sep 28, 2021 | Sept. 28, 2021, 8 p.m. |
CHRS | Sale | 100,150 | Sep 27, 2021 | Sept. 28, 2021, 8 p.m. |
CHRS | Sale | 286,076 | Sep 29, 2021 | Sept. 28, 2021, 8 p.m. |
NTRA | Purchase | 2,400 | Jul 22, 2021 | July 25, 2021, 8 p.m. |
KRTX | Purchase | 636 | Jul 02, 2021 | July 6, 2021, 8 p.m. |
AVTE | Purchase | 357,142 | Jul 02, 2021 | July 5, 2021, 8 p.m. |
$NTRA Executives and Stock Owners with Insider Trades
-
Steven Leonard Chapman, CEO AND PRESIDENT
-
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER
-
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER
-
Robert Alan Schueren, CHIEF OPERATING OFFICER
-
Matthew Rabinowitz, EXECUTIVE CHAIRMAN
-
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS
-
John Fesko, PRESIDENT, CHIEF BUS. OFFICER
-
Daniel Rabinowitz, CHIEF LEGAL OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.